{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:12:33Z","timestamp":1779887553745,"version":"3.53.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The year 2020 saw the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which became a great threat to public health worldwide. The exponential spread of the disease with millions of lives lost worldwide saw the emergence of an accelerated vaccine development with emergency approval from well-known regulatory bodies such as the US Food and Drug Administration, followed by widespread vaccine deployment despite a paucity in safety profile data. This issue becomes even more pronounced when it involves expectant mothers considering the possible undesirable effect toward the unborn child.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This was a retrospective cohort study which was conducted at six general hospitals in the state of Penang, Malaysia. All the pregnant employees who have consented to take the mRNA COVID-19 vaccine and participate in this study were monitored from the time of their first vaccination and up to 28 days after they delivered their babies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All the participants had adequate maximum vertical pocket (MVP) and no obvious anomalies or detection of intrauterine growth restriction (IUGR) were detected during the second trimester. However, one subject was reported to have miscarried during the second trimester. The reported mean neonate birth weight was 3.0 kg with the mean Apgar score of 8.8 and 9.8 at 1 and 5 min, respectively. Approximately seven (5.8%) neonates were reported to be small for their gestational age. Another three (2.5%) neonates were reported to have anomalies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>As a whole, the inference that can be made from this study is that mRNA COVID-19 vaccine appears to be safe in pregnant women regardless of the trimester as the findings did not show obvious safety warning signs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.876966","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:06:57Z","timestamp":1653289617000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals"],"prefix":"10.3389","volume":"10","author":[{"given":"Ann Lisa","family":"Arulappen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Danial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiyathri","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Thye","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairin","family":"Dulasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Soo","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.3346\/jkms.2020.35.e61","article-title":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2021.1658","article-title":"COVID-19 vaccination in pregnant and lactating women","volume":"325","author":"Adhikari","year":"2021","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.15585\/mmwr.mm6925a1","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B4","volume-title":"Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States","year":"2022"},{"key":"B5","volume-title":"Vaccinating Pregnant and Lactating Patients Against COVID19","year":"2021"},{"key":"B6","volume-title":"Interim Statement on COVID-19 Vaccination for Children and Adolescents","year":"2021"},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov."},{"key":"B8","volume-title":"Plasma Products Lot Release Certificates","year":"2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med."},{"key":"B10","volume-title":"Pulau Pinang: 2016 - 2019: Population Estimates based on the adjusted Population and Housing Census of Malaysia 2010","year":"2020"},{"key":"B11","volume-title":"Evaluation and Management Considerations for Neonates at Risk for COVID-19 [Online]","year":"2022"},{"key":"B12","volume-title":"Living Guidance for Clinical Management of COVID-19","year":"2021"},{"key":"B13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/1471-0528.14099","article-title":"EP1a.036: Small-for-gestational-age babies from Malaysian tertiary hospitals: a 5 year cohort study from the National Obstetric Registry, Malaysia.","volume":"123","author":"Krishnan","year":"2016","journal-title":"BJOG."},{"key":"B14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/03014460500075332","article-title":"A population-based study of birth defects in Malaysia","volume":"32","author":"Thong","year":"2005","journal-title":"Ann Hum Biol."},{"key":"B15","unstructured":"MyhealthM.\n          Preterm Babies [Online].2022"},{"key":"B16","doi-asserted-by":"publisher","first-page":"F249","DOI":"10.1136\/archdischild-2012-301767","article-title":"Neonatal infections in China, Malaysia, Hong Kong and Thailand","volume":"98","author":"Al-Taiar","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B17","unstructured":"Update on overall prevalence of major birth defects\u2013Atlanta, Georgia, 1978-200515MMWR Morb Mortal Wkly Rep.572008"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.15585\/mmwr.mm6543a1","article-title":"Effects of maternal age and age-specific preterm birth rates on overall preterm birth rates - United States, 2007 and 2014","volume":"65","author":"Ferr\u00e9","year":"2016","journal-title":"Morbid Mortal Wkly Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG practice bulletin no. 200: early pregnancy loss.","volume":"132","year":"2018","journal-title":"Obstet Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20172533","DOI":"10.1542\/peds.2017-2533","article-title":"Morbidity and mortality in small for gestational age infants at 22 to 29 weeks' gestation","volume":"141","author":"Boghossian","year":"2018","journal-title":"Pediatrics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S692","DOI":"10.1016\/j.ajog.2017.12.013","article-title":"Customized vs INTERGROWTh 21st standards for the assessment of birthweight and stillbirth risk at term","volume":"218","author":"Francis","year":"2018","journal-title":"Am J Obstetr Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/AOG.0000000000004166","article-title":"Evaluating the association of stillbirths after maternal vaccination in the vaccine safety datalink","volume":"136","author":"Panagiotakopoulos","year":"2020","journal-title":"Obstet Gynecol."},{"key":"B23","volume-title":"Miscarriage. [Updated 2021 Jun 29].","author":"Dugas","year":"2021"},{"key":"B24","volume-title":"Infant Mortality Rates by State","year":"2021"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.876966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:07:09Z","timestamp":1653289629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.876966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":24,"alternative-id":["10.3389\/fpubh.2022.876966"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.876966","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"article-number":"876966"}}